Centrix Pharmaceutical announces Clofera™,
a unique antitussive and nasal
decongestant for the temporary relief of cough and nasal congestion
August 14, 2009 – BIRMINGHAM, Ala. – Centrix Pharmaceutical,
Inc., a privately-held specialty pharmaceutical company focused
on Pediatrics and Women's Health, announced
plans to commercially launch Clofera™ for the temporary
relief of cough and nasal congestion.
Clofera™ is indicated
for the temporary relief of cough and nasal congestion due
to the common cold, hay fever, or other upper respiratory allergies.
Clofera™ contains
a non-narcotic antitussive, chlophedianol hydrochloride, in
addition to nasal decongestant, pseudoephedrine hydrochloride.
The product is specifically formulated without dyes, sugar,
alcohol or gluten to meet particular consumer needs and address
patient sensitivities. Clofera™ is expected to release
during the beginning of the fourth quarter.
"We are pleased
to introduce Clofera to temporarily control the cough reflex,
therefore reducing the intensity of coughing with a product
that is free of narcotic effects. Clofera provides physicians
with another therapeutic option in the management of cough
and congestion associated with allergic rhinitis or the common
cold. The release of Clofera further compliments our goal to
develop and expand the Centrix specialty portfolio," stated
John R. (Bob) Booth, President and CEO of Centrix Pharmaceutical.
About
Clofera™
Clofera™ temporarily controls the cough reflex, temporarily
relieves nasal congestion, swollen nasal passages, sinus congestion
and pressure. Clofera™ should
not be used in patients taking monoamine oxidase inhibitors
or with known hypersensitivity to any of the components of
the product. Patients with a chronic cough, asthma, emphysema,
mucus production, heart disease, high blood pressure, thyroid
disease, diabetes, or enlarged prostate should consult physician
before use. Recommended dosage should not be exceeded. Clofera™ contains
no dextromethorphan, antihistamines, sugar, alcohol, or dyes
and is gluten free. Clofera™ will be available in grape
flavor.
About Centrix Pharmaceutical, Inc.
Centrix Pharmaceutical is a privately-held specialty pharmaceutical
company focused in Pediatrics and Women's Health. Headquartered
in Birmingham, AL, the Company's products are marketed
by its dedicated sales force in the United States. For more
information about Centrix Pharmaceutical, Inc. visit www.cenrx.com.
